Objective: Determine the change in general health-related quality of life (HRQOL) after cochlear implantation and association with speech recognition. Study Design: Meta-analysis. Methods: Search was performed following the PRISMA statement using PubMed, Medline, Scopus, and CINAHL. Studies on adult cochlear implant (CI) patients measuring HRQOL before and after cochlear implantation were included. Standardized mean difference (SMD) for each measure and pooled effects were determined. A metaanalysis of correlations was also performed between all nondisease-specific patient-reported outcome measures (PROMs) and speech recognition after cochlear implantation. Results: Twenty-two articles met criteria for meta-analysis of HRQOL improvement, but 15 (65%) were excluded due to incomplete statistical reporting. From the seven articles with 274 CI patients that met inclusion criteria, pooled analyses showed a medium positive effect of cochlear implantation on HRQOL (SMD ¼ 0.79). Subset analysis of the HUI-3 measure showed a large effect (SMD ¼ 0.84).
Cochlear implantation is the gold standard for treatment for individuals with severe to profound bilateral sensorineural hearing loss. With rising health care costs, much focus has been recently placed on the effectiveness of treatments, especially surgical procedures such as cochlear implantation. Since 2002, the National Institutes of Health has been focusing considerable attention towards patient-reported outcomes to ensure treatments are improving outcomes that are important to patients and, thus, providing significant benefit (1).
Quality of life (QOL) patient-reported outcome measures (PROMs) are commonly used to determine the impact of an intervention on an individual's life. These PROMs can be subdivided into two major categoriesgeneral health and disease-specific. The former are generalizable instruments that are meant to be applied to large, diverse populations to evaluate overall QOL or an individual construct. In contrast, disease-specific instruments are typically validated for a particular population that share a common health condition or disability. General health-related quality of life (HRQOL) PROMs are the most commonly used instruments for economic analysis to determine the cost effectiveness of a particular treatment through measurement of total health (2, 3) . The importance of using QOL PROMs has been strengthened recently by an increased emphasis by the Center for Medicare and Medicaid Services (CMS) and the Food and Drug Administration (FDA) requirement to report these data (4, 5) .
In contrast to the growing importance of patientreported outcomes, open-set speech recognition scores measured in quiet and in noise continue to be the gold standard for assessing outcomes and benefit in adult CI recipients. In evaluating the literature, there does not appear to be a strong relationship between speech recognition ability and patient self-report (6) (7) (8) (9) . Reasons for these discrepancies are likely twofold. First, the complex communication, social, and emotional situations that CI users experience may not be fully represented by word or sentence recognition alone. Second, the manner in which cochlear implantation improves QOL likely extends well beyond improvements in speech recognition. Due to the routine use of word and sentence recognition scores in reporting CI outcomes and the increasing importance of reporting QOL PROMs, it is important to systematically determine the extent to which these measures correlate.
Our previous work has shown a very large effect size of cochlear implantation on QOL when measured with hearing and CI-specific PROMs (10) . For the current study, we sought to determine how this impact compares when using HRQOL PROMs that are routinely reported in the literature, but were not developed for or validated on individuals with hearing loss. This is an important comparison as the health usefulness and economic analyses of cochlear implantation are typically calculated using HRQOL PROMs. This study will help determine their usefulness in the CI population. A second meta-analysis assessed the association of HRQOL PROMs with speech recognition ability.
MATERIALS AND METHODS

Search Methods
Literature search was performed in accordance with the Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) statement (11) . The PubMed, Scopus, and OVID/Medline databases were independently searched by two authors for the search terms: ''cochlear implant'', ''cochlear implantation'', ''quality of life'', and ''patient-reported outcome measures''. This search identified 1,281 articles, of which, 591 were unique articles after eliminating duplicates (Fig. 1) . These 591 articles were first reviewed by abstract, which eliminated 360 articles. There were 231 articles remaining, which underwent full-text review for inclusion (one article satisfied criteria for both analyses). Disputes regarding the inclusion of a study were mediated with a third author to reach consensus.
Letters to the editor, abstracts, book chapters, case reports, and articles not published or translated in English were excluded. There were no date range limitations on date of publication. Studies with patients younger than 18 years old in the cohort were excluded. Analyzing PROMs in pediatric patients involves many different factors than adults, thus we limited the scope of this study to adult patients (12) .
The last time point available for each study was used for data collection. Data reported in graphical plots were not extracted for meta-analysis unless numerical data were available. We attempted to contact authors if we could not extract complete data from their publication; some authors provided additional data to allow inclusion of their study in our analysis.
Data Extraction
When selecting articles for meta-analysis of HRQOL improvement, studies meeting the following inclusion criteria were ultimately selected: assessment of HRQOL in an adult CI cohort before and after surgery (or in a post-treatment cohort versus a control cohort); sample size, mean, and standard deviation available for PROM data; and follow-up of at least 6 months. Two authors independently obtained data from articles including: year of publication, author, number of patients, patient demographics, and HRQOL PROM scores.
When selecting articles for meta-analysis of correlations, studies meeting the following inclusion criteria were used: correlation values of speech recognition scores versus any general PROM in an adult cohort after cochlear implantation; complete data available (sample size and Pearson or Spearman correlation values); and postoperative follow-up of at least 3 months. Two authors independently obtained data from articles including: author, year of publication, number of patients, patient demographics, speech recognition measure used, and correlation values. Studies included in this analysis did not require reporting of preimplantation PROM data. Rather, this analysis aimed to evaluate the correlation of speech recognition ability and each respective PROM at the latest available time point after implantation.
Data reported in graphical plots were not extracted unless numerical values were published. We contacted authors to obtain complete details of results in the event of incomplete data to allow inclusion of their study. PROMs using a reverse scale (reduction in scores represent improved QOL) had standardized mean difference (SMD) values multiplied by negative one for analysis. Level of evidence for each selected article was evaluated with the Oxford Center for Evidence-Based Medicine (13) .
Meta-analysis of HRQOL Improvement Statistical Method
Meta-analysis of included studies evaluating the impact of cochlear implantation on HRQOL with a continuous measure (comparison of means and standard deviations between preimplantation and post-implantation) was performed with Cochrane Review Manager (RevMan) version 5.3 (Nordic Cochrane Centre, Cochrane Collaboration, 2011, Copenhagen, Denmark). Fixed-effects and random-effects models were used in this study. Under the fixed-effects model, it is assumed that all studies come from a common population, and that the effect size as measured through SMD is not significantly different among the different trials. This assumption is tested by the heterogeneity test or I 2 statistic. If this test yields a low probability value ( p < 0.05), then there is a high likelihood the fixed-effects model is invalid and the random-effects model is more appropriate. The random-effects model incorporates both the random variation within the studies and the variation between the different studies (14) . The random-effects model provides a more conservative estimate (i.e., a wider confidence interval), but the results from the two models typically agree when there is no heterogeneity. When heterogeneity was present, the random-effects model was the preferred model.
Potential publication bias was evaluated by visual inspection of the funnel plot and Egger's regression test, which statistically examines the asymmetry of the funnel plot (15) . For this analysis, the null hypothesis was that there is no difference between preimplantation and postimplantation PROM scores. Analysis was performed on two subsets of PROMs: the Health Utilities Index 3 (HUI-3) HRQOL PROM and other HRQOL PROMs. Data are presented as SMD (95% confidence interval). The following thresholds were used for subjective assessment of effect size: 0.2-small effect, 0.5-medium effect, and 0.8-large effect (16) .
Meta-analysis of Correlations Statistical Methods
A meta-analysis of correlations was performed for correlations between speech recognition and HRQOL PROMs using MedCalc 17.2 (MedCalc Software, Ostend, Belgium). Heterogeneity testing was performed as previously described. Each study was weighted according to the number of patients included. MedCalc uses the Hedges-Olkin method for calculating the weighted summary correlation coefficient under the fixed-effects model, using a Fisher Z transformation of the correlation coefficients (17) . Under the random-effects model, the heterogeneity statistic is incorporated to calculate the summary correlation coefficient (19) . For this analysis, the null hypothesis was that speech recognition ability and PROM scores do not correlate. The following thresholds were used for subjective assessment of correlation values (r): 0 to 0.3, negligible; 0.3 to 0.5, low; 0.5 to 0.7, medium; 0.7 to 0.9, high; 0.9 to 1.0, very high (18, 19) .
RESULTS
Meta-analysis of HRQOL Improvement
Twenty-two articles met many of the inclusion criteria for outcomes analysis, but 15 (68%) were excluded due to incomplete statistical reporting, leaving seven articles for analysis (Table 1) . From the seven articles, 274 patients were included in the analysis with 100% of patients having published sex data (46% men, 54% women). The mean age across all study cohorts ranged from 49 to 62 years. Pooled analyses showed a medium positive effect of cochlear implantation on HRQOL (SMD ¼ 0.79 [0. 39-1.19] ). Subset analysis of the (Fig. 2) . To investigate the presence of publication bias, inspection of the funnel plot of effects calculated from individual studies was performed. According to funnel plots and the Egger's test, there was no indication of publication bias ( p ¼ 0.272) among the set of studies included in this meta-analysis.
Five studies in our analysis used the HUI PROM (6, (20) (21) (22) (23) . Both the HUI-2 and HUI-3 are used to evaluate QOL (3). The HUI-2 classification system uses seven domains (sensation, mobility, emotion, cognitive, self-care, pain, fertility) whereas the HUI-3 classification uses nine alternative domains (vision, hearing, speech, walking, dexterity, emotion, cognition, pain). The HUI-3 hearing domain directly ascertains hearing function by asking patients if they can perceive what others are saying in various settings. For example, the HUI-3 asks patients if they are: ''Able to hear what is said in a conversation with one other person in a quiet room, without a hearing aid, but unable to hear what is said in a group conversation with at least three other people even with a hearing aid''. The HUI-2 sensation domain collects similar but more basic information regarding hearing function while combining it with other senses. For example, the HUI-2 asks if patients can ''See, hear, or speak with limitations even with equipment''. All five included studies utilizing the HUI found significant improvement in the hearing or sensation domain for CI patients. Only one study using the HIU-3 found improvement in the speech domain for CI patients (22) . Additionally, two of the five studies of utilizing either HUI found significant improvement in the emotion domain for CI patients (20, 23) . No other domains except those mentioned above showed significant improvement in the five included studies utilizing the HUI.
Damen et al. (6) used the 36-item short form (SF-36) and found no significant change in the physical summary or mental summary for CI patients. Specifically, significant improvement for CI patients was found only in the mental health subdomain of the mental summary. 
Meta-analysis of Correlations
Nine articles met criteria for inclusion in this analysis with none being excluded due to incomplete statistical reporting (Table 2) (6, 7, 9, (26) (27) (28) (29) (30) (31) . A total of 550 patients were included with 41% of the patients having published sex data (45% men, 55% women). The mean age across all studies ranged from 36.8 to 63.4 years. Vermeire et al. (29) found the highest correlations among HRQOL PROMs in our study (r ¼ 0.83), correlating the Glasgow Benefit Inventory (GBI) and word recognition in quiet. This finding was an outlier as the three other studies correlating GBI versus word recognition in quiet found correlations of 0.25, 0.28, and 0.34 (28) (29) (30) . The outlier study also used the smallest sample size (n ¼ 24) resulting in a large confidence interval (0.64-0.92).
Only two other studies found an overall medium correlation or higher (r ! 0.50). Francis et al. (9) found a correlation of 0.55 for both word recognition in quiet and sentence recognition in quiet with the HUI measure; when analyzing specific domains, this study found the highest correlations of the HUI emotion domain versus word recognition in quiet (r ¼ 0.47) and sentence recognition in quiet (r ¼ 0.48), but surprisingly found negligible correlations with the HUI hearing domain. Knutson et al. (26) found a medium correlation (r ¼ 0.54) between the Rathus Assertiveness Scale (RAS) and word recognition in quiet. The RAS attempts to determine a patient's social confidence and assertiveness. All other studies reviewed found negligible or low correlations with speech recognition abilities on review of PROM total score correlations or published PROM subdomain correlations.
DISCUSSION
HRQOL PROMs are instruments that assess the patient's perspective of their health, illness, or the effects of interventions (32) . Uses for PROMs include screening measures, effectiveness metrics, clinical trial endpoints, and economic assessments. The current study is a metaanalysis of HRQOL improvement following cochlear implantation and the first meta-analysis to assess the correlations between speech recognition and HRQOL PROMs in CI patients. We limited these analyses to HRQOL PROMs that are commonly used for a wide range of patients and conditions as we sought to understand the usefulness of these non-disease-specific PROMs in the CI population.
We found two previous studies performing reviews of the literature of PROM changes after CI; however, they used different inclusion criteria than our study (33, 34) . Gaylor et al. (33) included many studies that reported preoperative QOL using a retrospective question format, i.e., asking patients after implantation regarding their health status before implantation. This retrospective approach to data gathering is limited by recall bias and, therefore, studies that included data gathered in this manner were excluded from our analysis. In contrast to Gaylor et al., we did not include the GBI in our metaanalysis of HRQOL improvement, as this measure requires the patient to subjectively assess their improvement following cochlear implantation (35) . The review by Loeffler et al. (34) included qualitative analyses of HRQOL improvement and did not perform a quantitative analysis. Our literature search found no quantitative meta-analyses of correlations of speech recognition ability and HRQOL PROMs in CI patients.
In the current study, we found that cochlear implantation was associated with medium positive effect of cochlear implantation in HRQOL, which is a far smaller effect than we reported for hearing and CI-specific QOL PROMs (SMD ¼ 1.82 and 1.69, respectively) (10). This is expected as HRQOL PROMs do not typically include questions related to communication and instead focus on topics that may be unrelated to cochlear implantation, such as bodily pain, physical function, and vision. HRQOL PROMs, such as HUI-3 and SF-36, are often used to determine the economic usefulness of surgical interventions such as cochlear implantation. Thus, given the larger effect on QOL observed when using hearing/ CI-specific, HRQOL measures may underestimate the quality-adjusted life years and other economic impacts of cochlear implantation. This difference in self-reported benefit may also render HRQOL PROMs insensitive to the economic benefits of a second cochlear implant, electroacoustic listening modalities, and auditory rehabilitation services.
SMDs from all HRQOL PROMs in our study ranged from À0.37 to 2.13 with a corresponding I 2 value of 86%, indicating a high amount of heterogeneity. This heterogeneity may result from HRQOL PROMs measuring different domains of QOL and/or populations evaluated across studies were heterogeneous in the impact of cochlear implantation on their daily lives. It is important to note that these HRQOL measures have not been validated in individuals with hearing loss or patients with CIs. Therefore, these inconsistent results may represent individual differences in domains unrelated to cochlear implantation that may represent the diverse population that are implanted rather than changes related to implantation.
The above emphasizes the importance of using QOL PROMs developed and validated in the CI population. With improved communication abilities, we hypothesize that patients' social wellness and participation will also improve, and loneliness, isolation, and depression will decrease (26, 36, 37) . However, the psychosocial changes that accompany an individual reentering the hearing world after cochlear implantation may be unique to the CI population and difficult to assess with more general HRQOL PROMs.
Given that speech recognition ability has traditionally been the primary outcome measure in cochlear implantation, it was important to understand the correlation between speech recognition scores and patient self-report through HRQOL PROMs. The narrow range of pooled correlation values (r ¼ 0.32-0.45) demonstrates that PROMs have a low correlation with all categories of speech recognition testing. These correlation values are similar to and slightly higher than the correlations between hearing/CI-specific QOL measures and speech recognition scores (0.20-0.28 and 0.21-0.26, respectively) (10) . Moreover, the coefficient of determination (or the proportion of variance attributable to the independent variable) reveals that only 10.2 to 20.3% of the variation in HRQOL can be attributed to speech recognition abilities, as measured by word and sentence recognition scores. Interestingly, our previous work showed that speech recognition ability accounts for even less of the variation in QOL when measured using hearing and CI-specific QOL instrument (4.8-5.8%) (10) . This weak association between patient reported improvement and measured speech recognition abilities underscores the importance of using disease-specific PROMs to evaluate the benefits of cochlear implantation for individual patients. How individuals listen, communicate, and interact with their environment is likely far more complex than conventional speech recognition tasks, even when performed in background noise.
The National Institutes of Health established the Patient-Reported Outcomes Measurement Information System (PROMIS) in 2004 to improve the assessment of patient-reported outcomes and development of instruments with the goals of reliability, precision, and construct validity (38) . PROMIS has created QOL instruments that have undergone rigorous validity testing for cross-sectional, content, and clinical validity (39) (40) (41) . Creating these instruments also consists of including patients in the question development process to specifically address the QOL-related challenges facing the population of interest. No CI-specific PROM has been developed using this rigorous validation methodology. A PROM specifically developed for and validated on the CI population, would expand our ability to understand and report the communication, social, emotional, and other experiences of CI users.
Our study is limited by biases inherent to many systematic reviews of the literature, particularly publication bias. In addition, the speech recognition measures used by the included studies varied widely. We performed separate analyses for word recognition in quiet, sentence recognition in quiet, and sentence recognition in noise in an attempt to minimize these differences. Pooled estimates account for these differences, as study differences such as this are common in meta-analyses. We were unable to perform a multivariate analysis that might account for population differences as individual patient data such as age, sex, and hearing and CI related information were unavailable. With respect to correlation data, many studies excluded from our analysis stated that no significant correlations were found, but did not cite numerical data; therefore, these studies could not be included in our analysis. Additionally, many studies had incomplete statistical data, particularly standard deviation, and had to be excluded.
CONCLUSION
A meta-analysis of HRQOL improvement showed a medium positive effect of cochlear implantation on HRQOL. In contrast, a meta-analysis of correlations showed negligible pooled correlations between speech recognition scores and HRQOL PROMs. Diseasespecific measures that focus on domains of significance to QOL in CI patients have greater usefulness in the CI population.
